首页> 外文期刊>Cytotechnology >Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors
【24h】

Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors

机译:评价无血清培养基MDSS2在生物反应器中的Vero细胞上生产脊髓灰质炎病毒的能力

获取原文
获取外文期刊封面目录资料

摘要

The serum-free medium MDSS2 (Merten et al., 1994), was used for cultivating Vero cells as well as for producing poliovirus (Sabin type 1) in static and in perfused micro-carrier cultures. At slightly different growth rates of 0.0120/h and 0.0106/h, respectively, static cultures in serum-containing (SCM) and serum-free (SFM) medium produced titers of 106.75 and 106.67 TCID50 per 50 μl; signifying a specific productivity of 0.89 and 1.07 TCID50/c.Serum-free bioreactor cultures of Vero cells on DEAE-dextran microcarriers at 6.25 g/l produced cell densities of about 1.5×106c/ml. After infection with virus (multiplicity of infection (MOI) 0.1–0.3) titers of about 6.3×108 TCID50/ml were obtained, signifying an average specific productivity of 7.1 TCID50/c.h. Although these values were 4 and 2 fold, respectively, higher than in classical resum-based production processes (Montagnon et al. Dev. biol. Stand. 1981, 47, 55), a reference culture, for which cell growth was done in SCM and only virus production was done in SFM, produced 2×109 TCID/ml with an average specific virus production rate of 18.9 TCID50/c.h. The differences between the fully serum-free and our reference process were mainly due to physiological differences of cells grown in SCM and SFM and also due to strongly modified consumption kinetics after virus infection leading to limitations of one or several essential medium compounds, like glucose and amino acids. Avoiding these limitations by increasing the residual concentration of glucose, glutamine, histidine, and SH-amino acids, led to specific virus production rates (of about 17.9 TCID59/c.h.) comparable to those found in the reference virus production process. The optimisation of the production of the poliovirus (Sabin 1) will be described with respect to the modification of the medium composition.
机译:无血清培养基MDSS2(Merten等,1994)用于在静态和灌注微载体培养中培养Vero细胞以及生产脊髓灰质炎病毒(1型萨宾菌)。在含血清(SCM)和无血清(SFM)培养基中的静态培养分别以0.0120 / h和0.0106 / h的速率稍有不同时,每50μl产生的滴度分别为106.75和106.67 TCID50。表示单位生产力为0.89和TCID50 / c。在DEAE-葡聚糖微载体上以6.25 g / l的Vero细胞进行的无血清生物反应器培养产生的细胞密度约为1.5×106c / ml。感染病毒后(感染复数(MOI)为0.1–0.3),滴度约为6.3×108 TCID50 / ml,表明平均比生产率为7.1 TCID50 / c.h。尽管这些值分别是传统的基于简历的生产过程的4倍和2倍(Montagnon等人,Dev。biol。Stand。1981,47,55),这是一种在SCM中完成细胞生长的参考培养物在SFM中仅产生病毒,产生2×109 TCID / ml,平均比病毒产生率为18.9 TCID50 / ch完全无血清和参考过程之间的差异主要是由于在SCM和SFM中生长的细胞的生理差异,也归因于病毒感染后强烈改变的消耗动力学,导致一种或几种基本培养基化合物(如葡萄糖和氨基酸。通过增加葡萄糖,谷氨酰胺,组氨酸和SH-氨基酸的残留浓度来避免这些局限性,可产生与参考病毒生产过程中可比的特定病毒生产速度(约17.9 TCID59 / c.h。)。关于脊髓灰质炎病毒(Sabin 1)的生产的优化将在培养基组成的修饰方面进行描述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号